Oct. 25 at 7:55 PM
$COCH The 10/07 Doji stands out like a sore thumb, as the Company decided to dilute literally the day following 100-200% spike from
$0.75 that I specifically mentioned to the board 1-2wks prior (below). Well-the Company remains a strong small bio consideration (IMO), consolidating at the
$0.75-0.85 support range that I mentioned previously, now with a stronger balance sheet. Note: all placements have been made with
$1.30 strike, so investors here are purchasing/acquiring at a sizeable discount. DCA at/around
$0.8 with 50-100% upside (IMO) near/intermediate term.